These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 2249907)

  • 1. The natural history of uveitis.
    Nussenblatt RB
    Int Ophthalmol; 1990 Oct; 14(5-6):303-8. PubMed ID: 2249907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications.
    Nussenblatt RB
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3131-41. PubMed ID: 1748544
    [No Abstract]   [Full Text] [Related]  

  • 3. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.
    Caspi RR; Chan CC; Fujino Y; Najafian F; Grover S; Hansen CT; Wilder RL
    J Neuroimmunol; 1993 Sep; 47(2):177-88. PubMed ID: 8370769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the immune system in uveitis induced in animals.
    Hylkema HA
    Doc Ophthalmol; 1988 Dec; 70(4):339-51. PubMed ID: 3075176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-antigen: molecular mimicry may play a role in autoimmune uveitis.
    Shinohara T; Singh VK; Yamaki K; Abe T; Tsuda M; Suzuki S
    Prog Clin Biol Res; 1991; 362():163-90. PubMed ID: 2003125
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.
    Yamamoto JH; Minami M; Inaba G; Masuda K; Mochizuki M
    Br J Ophthalmol; 1993 Sep; 77(9):584-9. PubMed ID: 8218058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
    Wildner G; Thurau SR
    Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in the eye and its regulation.
    Gery I; Streilein JW
    Curr Opin Immunol; 1994 Dec; 6(6):938-45. PubMed ID: 7710718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed immune mechanisms in uveitis and their modulation.
    Nussenblatt RB; Palestine AG; Chan CC
    Int Ophthalmol Clin; 1985; 25(2):81-93. PubMed ID: 3159706
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report.
    Nussenblatt RB; Whitcup SM; de Smet MD; Caspi RR; Kozhich AT; Weiner HL; Vistica B; Gery I
    Ann N Y Acad Sci; 1996 Feb; 778():325-37. PubMed ID: 8610986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic and clinical immunology in uveitis.
    Nussenblatt RB
    Jpn J Ophthalmol; 1987; 31(3):368-74. PubMed ID: 3430854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of synthetic peptides in the study of experimental autoimmune uveitis.
    Donoso LA; Gregerson DS; Fling SP; Merryman CF; Sery TW
    Curr Eye Res; 1990; 9 Suppl():155-61. PubMed ID: 1696532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of anterior-chamber-associated immune deviation in the pathogenesis of uveitis.
    Streilein JW
    Dev Ophthalmol; 1992; 23():86-93. PubMed ID: 1730378
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen-directed retention of an autoimmune T-cell line.
    Lightman SL; Caspi RR; Nussenblatt RB; Palestine AG
    Cell Immunol; 1987 Nov; 110(1):28-34. PubMed ID: 2960461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic suppression of experimental autoimmune uveitis].
    Thurau SR; Caspi RR; Chan CC; Weiner HL; Nussenblatt RB
    Fortschr Ophthalmol; 1991; 88(4):404-7. PubMed ID: 1838532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites.
    Gregerson DS; Fling SP; Obritsch WF; Merryman CF; Donoso LA
    Cell Immunol; 1989 Oct; 123(2):427-40. PubMed ID: 2790968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a uveitogenic cyanogen bromide peptide of bovine retinal S-antigen and preparation of a uveitogenic, peptide-specific T cell line.
    Gregerson DS; Obritsch WF; Fling SP
    Eur J Immunol; 1987 Mar; 17(3):405-11. PubMed ID: 3494613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases.
    Bose T; Diedrichs-Möhring M; Wildner G
    Autoimmun Rev; 2016 Dec; 15(12):1181-1192. PubMed ID: 27639836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.